Bank Of America Corp Bio Xcel Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 73,426 shares of BTAI stock, worth $41,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,426
Previous 47,368
55.01%
Holding current value
$41,852
Previous $133,000
30.08%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BTAI
# of Institutions
77Shares Held
7.24MCall Options Held
101KPut Options Held
205K-
Armistice Capital, LLC New York, NY2.99MShares$1.7 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA970KShares$553,1450.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$251,1900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$152,0290.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA204KShares$116,0600.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $16M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...